Real-time enrollment status for this liver cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06921785 |
| Recruiting Status | Recruiting |
| Condition | Liver Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,220 participants |
| Active Locations | 15 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 9, 2026 (Jan 9, 2026) |
As of March 2, 2026: Clinical trial NCT06921785 is currently recruiting participants. This clinical trial study for liver cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06921785 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06921785 was last updated Jan 9, 2026 (January 9, 2026). HelloStudys verifies this status automatically.